A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

Columbia University Medical Center - Department of Pediatrics, New York

Columbia University Medical Center, New York

Children's Hospital of Philadelphia, Philadelphia

The University of North Carolina at Chapel Hill, Chapel Hill

Atrium Health, Charlotte

Medical University of South Carolina, Charleston

Children's Healthcare of Atlanta, Atlanta

Johns Hopkins All Children's Hospital, St. Petersburg

Tristar Medical Group Children's Specialists/Sarah Cannon Center for Blood Cancers, Nashville

University of Mississippi Medical Center, Jackson

Nationwide Children's Hospital, Columbus

The James Cancer Hospital, Columbus

University Hospitals Rainbow Babies & Children's Hospital, Cleveland

Cleveland Clinic, Cleveland

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

Cook Children's, Fort Worth

Children's Hospital Colorado, Aurora

UCSF Benioff Children's Hospital, Oakland

Smilow Cancer Hospital, New Haven

Hackensack University Medical Center, Hackensack

Ottawa Hospital Research Institute, Ottawa

Princess Margaret Cancer Centre, Toronto

Centre Hospitalier Universitaire Sainte-Justine, Montreal